488
Views
16
CrossRef citations to date
0
Altmetric
MIDDLE EAR

Effect of combination of montelukast and levocetirizine on otitis media with effusion: a prospective, placebo-controlled trial

, , , , , & show all
Pages 1266-1272 | Received 21 Apr 2013, Accepted 04 Jul 2013, Published online: 26 Aug 2013

References

  • Gordon MA, Grunstein E, Burton WB. The effect of the season on otitis media with effusion resolution rates in the New York Metropolitan area. Int J Pediatr Otorhinolaryngol 2004;68:191–5.
  • Alles R, Parikh A, Hawk L, Darby Y, Romero JN, Scaddinq G. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol 2001;12:102–6.
  • Newacheck PW, Stoddard JJ. Prevalance and impact of multiple childhood chronic illnesses. J Pediatr 1994;124:40–8.
  • Krouse JH, Brown RW, Fineman SM, Han JK, Heller AJ, Joe S, et al. Asthma and unified airway. Otolaryngol Head Neck Surg 2007;136:S75–106.
  • Hurst DS, Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy 2000;55:435–41.
  • Brodsky L, Faden H, Bernstein J, Stanievich J, Decastro G, Volovitz B, et al. Arachidonic acid metabolites in middle ear effusion in children. Ann Otol Rhinol Laryngol 1991;100:589–92.
  • van Adelsberg J, Philip G, LaForce CR, Weinstein SF, Menten J, Malice MP, et al. Randomized controlled trial evaluating the clinical benefit of montelukast sodium for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003;90:214–22.
  • Doyle WJ, Friedman R, Friedman P, Fireman P, Bluestone CD. Eustachian tube obstruction after provocative nasal antigen challenge. Arch Otolaryngol 1984;110:508–11.
  • Skoner DP, Doyle WJ, Chamovitz AH, Fireman P. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg 1986;112:840–2.
  • Tachibana F, Shimada T, Hori Y, Wada Y, Ishitani Y, Koike Y. Platelet activating factor and leukotrienes in acute otitis media, secretory otitis media and chronic otitis media on the acute exacerbation. Auris Nasus Larynx 1996;23:20–5.
  • Frady RP, Parker WA, Jackson RT. Studies on permeability of the middle ear mucosa. The feasibility of blocking, inflammatory mediators. Arch Otolaryngol 1977;103:47–51.
  • Ting S, Rauls DO, Reiman BE. Inhibitory effect of hydroxazine on antigen-induced histamine release in vivo. J Allergy Clin Immunol 1985;75:63–6.
  • Suzuki M, Kawauchi H, Mogi G. Clinical efficacy of an antiallergic drug on otitis media with effusion in association with allergic rhinitis. Auris Nasus Larynx 1999;26:123–9.
  • Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, et al. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr 2003;143:377–85.
  • Combs JT. The effect of montelukast sodium on the duration of effusion of otitis media. Clin Pediatr (Phila) 2004;43:529–33.
  • Schoem SR, Willard A, Combs JT. A prospective, randomized, placebo-controlled, double-blind study of montelukast's effect on persistent middle ear effusion. Ear Nose Throat J 2010;89:434–7.
  • Aynali G, Yariktaş M, Yasan H, Karahan N, Başpinar S, Tüz M, et al. The effects of methyprednisolone, montelukast and indomethacin in experimental otitis media with effusion. Int J Pediatr Otorhinolaryngol 2011;75:15–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.